Back to top
more

State Street SPDR S&P Biotech ETF: (XBI)

(Delayed Data from NYSE) As of Nov 21, 2025 03:45 PM ET

$116.96 USD

116.955
9,985,849

+3.13 (2.75%)

Volume: 9,985,849

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $116.61 -0.35 (-0.29 %) 7:16 PM ET

Zacks News

Sanghamitra Saha headshot

10 Top-Performing ETFs of the Past Decade

These ETFs have emerged out as one of the top performers in the past decade.

    Sweta Jaiswal, FRM headshot

    Top ETF Areas for 2020

    As ETF investing constantly climbs the popularity charts, we highlight a few good ETF areas that investors can bank on for 2020.

    Sweta Killa headshot

    Biotech Leading in Q4: Best ETFs & Stocks

    We highlight five biotech ETFs and stocks that are leading the market in Q4.

    Sweta Killa headshot

    Decorating a Christmas Tree of Top-Ranked ETFs

    We have built a tree with the top-ranked ETFs that have the potential to outperform in 2020.

    Sanghamitra Saha headshot

    Santa Rally Sets In: Bet on 5 Top High-Beta ETFs With Value

    As Wall Street bulls rage on, investors can play high-beta ETFs to make the most of the Santa rally. These ETFs offer solid value and allay overpricing concerns.

    Sanghamitra Saha headshot

    Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

    Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

    Zacks Equity Research

    Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

    Sector ETF report for PBE

    Neena Mishra headshot

    Best ETF Strategies for 2020

    How should you position your portfolio for 2020? Here are some ideas.

    Neena Mishra headshot

    Why Biotech ETFs are Surging to New Highs

    increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

    Sweta Killa headshot

    Biotech ETFs Hit New Highs on Deal Activities

    Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

    Sanghamitra Saha headshot

    Deal or No Deal: Healthcare ETFs to Make a Sweep in 2020

    While all eyes are on the fate of the phase one trade deal between the United States and China, Healthcare sector can forget tension and soar higher in 2020 even if there is no deal.

    Sanghamitra Saha headshot

    Is Trade Scaring You? ETF Strategies for 2019 Holiday Season

    It is less likely that Santa alone will drive Wall Street this season as trade tensions persist. Overall, these ETF investing trends should stay strong.

    Sweta Jaiswal, FRM headshot

    A Guide to Biotech ETF Investing

    Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

    Sweta Killa headshot

    Biotech ETF (XBI) Hits a New 52-Week High

    This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

    Zacks Equity Research

    Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

    Sector ETF report for PBE

    Sweta Jaiswal, FRM headshot

    Why Biotech ETFs Surged in Monday's Trading Session

    Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to drive the biotech market.

    Sanghamitra Saha headshot

    Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

    Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

    Sweta Killa headshot

    Follow Morgan Stanley to Trade 2020 Election With ETFs

    Morgan Stanley outlined four outcomes of the 2020 election and its strategies for investors on how to make the most of them.

    Sweta Jaiswal, FRM headshot

    Biotech ETFs in Focus on Impressive Q3 Earnings Results

    Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q3 earnings results recently.

    Sanghamitra Saha headshot

    Value Biotech ETFs & Stocks to Buy Now

    Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.

    Sweta Killa headshot

    Healthcare ETFs Win in October: Here's Why

    The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

    Panel Of Zacks Experts headshot

    Navigating The Healthcare Industry: Science Fiction Turns to Reality

    Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!

    Sweta Killa headshot

    Biotech ETFs Surge on a Flurry of Positive News

    The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.